Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gavi

- PMLiVE

EU set to contribute €1bn to COVAX

EU had already pledged €500m to the international vaccine-sharing facility

- PMLiVE

First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%

COVID-19 vaccines are also reducing risk of hospitalisation

- PMLiVE

Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures

New data shows vaccine can be stored at temperatures of -25°C to -15°C

- PMLiVE

The World Bank is working towards standardising COVID-19 vaccine contracts

The World Bank is providing $12bn to help poor countries purchase and distribute vaccines, tests and treatments for COVID-19

- PMLiVE

Researchers suggest delaying second dose of Pfizer/BioNTech jab to protect more people

Canada-based researchers Skowronski and De Serres say first dose is ‘highly protective’

- PMLiVE

Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds

Report from the ONE Campaign considered vaccine supply deals agreed by G20 countries and the EU

- PMLiVE

Novavax to provide 1.1 billion COVID-19 vaccine doses to COVAX

Memorandum of understanding announced between Novavax, Gavi and the Vaccine Alliance

EU flag

Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU

The EU now currently has access to 2.6 billion COVID-19 vaccine doses from a range of companies

- PMLiVE

South African variant reduces antibody levels produced by Pifzer/BioNTech’s COVID-19 vaccine

Researchers noted it is 'unclear' what effect this reduction has on the vaccine's protection against the variant

- PMLiVE

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

Initial stage of the study will involve up to 90 healthy adult volunteers who will be exposed to COVID-19

- PMLiVE

J&J applies for EU authorisation for one-dose COVID-19 vaccine

Submission is based on top-line efficacy and safety data from the phase 3 ENSEMBLE trial

- PMLiVE

EU to begin new study programme investigating COVID-19 variants

Programme is expected to launch on Wednesday

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links